This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets. The contract has a ceiling value of $1,211.54 and is a firm fixed-price delivery order without a set-aside designation. The period of performance for this order extends to July 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 160-12.5 mg tablets. The firm-fixed-price contract has a ceiling value of $17,503.46 and a period of performance through May 14, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 160-25 mg tablets, with a ceiling value of $2,559.52 and a performance period through May 8, 2025. The contract is not set aside and was awarded as a firm-fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count bottles, with a ceiling value of $8,540.88. It is a delivery order contract with a firm fixed price. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of valsartan-HCTZ 320-25 mg tablets. The contract has a ceiling value of $2,626.19 and a completion date of January 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of valsartan-HCTZ 320-25 mg tablets in 90-count packages, with a ceiling value of $1,039.95 and a performance period extending to May 12, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation, indicating open competition....
This is a federal delivery order contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Valsartan-HCTZ 320-25 mg tablets. The contract has a ceiling value of $1,455.88 and a completion date of January 3, 2024. It is a firm-fixed-price contract awarded on January 2, 2024, with no set-aside requirements indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets. The award has a ceiling value of $3,918.15 and a completion date of March 24, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,880.93 and covers the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 160-25 mg tablets, with a ceiling value of $4,339.00 and a period of performance ending on May 22, 2025. This contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...